Dr. Bayer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Milo C. Huempfner Ambulatory Care Center
2851 University Avenue
Green Bay, WI 54311Phone+1 920-431-2500- Is this information wrong?
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1977 - 1979
- Akron General Medical Center/NEOMEDResidency, Internal Medicine, 1974 - 1977
- University of Wisconsin School of Medicine & Public HealthClass of 1974
Certifications & Licensure
- WI State Medical License 1979 - 2025
- MI State Medical License 1987 - 2018
- OH State Medical License 1975 - 1979
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL Start of enrollment: 2005 Apr 14
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsPhase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296).A. Bapsi Chakravarthy, Paul J. Catalano, Joshua K. Mondschein, David I. Rosenthal, Daniel G. Haller, Richard Whittington, Francis R. Spitz, Henry N. Wagner, Elin R. Si...> ;Gastrointestinal Cancer Research. 2012 Nov 1
- 78 citationsA phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503Anne M. Traynor, Ju Whei Lee, Gerald Bayer, John M. Tate, Sachdev P. Thomas, Miroslaw Mazurczak, David L. Graham, Jill M. Kolesar, Joan H. Schiller> ;Investigational New Drugs. 2010 Feb 1
- ECOG 1503: A phase II trial of triapine (NSC#663249) with gemcitabine (T/G) as 2nd line treatment of non-small cell lung cancer (NSCLC).Traynor AM, Levy DE, Bayer GK, Tate JM, Thomas SP, Mazurczak MA, Graham DL, Kolesar JM, Schiller JH> ;J. Clin. Oncol.. 2006-06-20
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- HSHS St. Mary's Hospital Medical CenterGreen Bay, Wisconsin
- Door County Medical CenterSturgeon Bay, Wisconsin
- HSHS St. Vincent HospitalGreen Bay, Wisconsin
- Clement J. Zablocki Veterans' Administration Medical CenterMilwaukee, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: